Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
RXRX
RXRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RXRX News
Recursion Pharmaceuticals Expands Partnership with Citeline to Enhance AI Drug Discovery
2d ago
Yahoo Finance
Analysis of AI Prospects for Alphabet and Recursion
Apr 01 2026
NASDAQ.COM
Recursion Appoints New Chief Medical Officer
Mar 25 2026
seekingalpha
RECURSION PHARMACEUTICALS INC NAMES VICKI GOODMAN AS CHIEF MEDICAL OFFICER, STARTING APRIL 6, 2026
Mar 25 2026
moomoo
AI Stocks Face Revaluation and Opportunities Ahead
Mar 22 2026
NASDAQ.COM
AI Stocks Face Challenges and Opportunities Amid Market Correction
Mar 22 2026
Fool
The Future of Drug Discovery Driven by AI
Mar 21 2026
Fool
Recursion Pharmaceuticals Faces Major Challenges Ahead
Mar 08 2026
Fool
Recursion Pharmaceuticals Leverages AI to Accelerate R&D
Mar 08 2026
NASDAQ.COM
PacBio Appoints New Board Member
Mar 05 2026
Newsfilter
PACBIO NAMES CHRIS GIBSON TO ITS BOARD OF DIRECTORS
Mar 05 2026
moomoo
Recursion Pharmaceuticals Q4 2025 Earnings Call Insights
Feb 25 2026
seekingalpha
Recursion Pharmaceuticals Q4 Earnings Exceed Expectations
Feb 25 2026
seekingalpha
Recursion Pharmaceuticals Stock Surges After Strong Earnings Report
Feb 25 2026
Benzinga
Totaligent Forms Joint Venture with GloMed for Biologics Distribution
Feb 25 2026
Newsfilter
Recursion Pharmaceuticals Q4 2025 Earnings Highlights
Feb 25 2026
seekingalpha
Show More News
